STOCK TITAN

Helix Acquisition III (HLXC) 10-K Filings

HLXC NASDAQ

Here are the 10-K annual reports from Helix Acquisition Corp. III (HLXC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow HLXC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLXC filings page.

Rhea-AI Summary

Helix Acquisition Corp. III is a Cayman Islands blank check company formed in 2025 to complete an initial business combination, primarily targeting healthcare or healthcare-related industries. It has no operations and only nominal assets outside of cash.

On January 26, 2026, the company completed an IPO of 17,250,000 Class A ordinary shares at $10.00 per share, plus a private placement of 497,500 Class A shares to the sponsor at $10.00, and placed $172,500,000 into a U.S. trust account. Public shareholders can redeem their Class A shares for cash in connection with a business combination or certain charter amendments, subject to limitations, while the sponsor and insiders have waived redemption rights on their founder and private placement shares.

Helix has 24 months from the IPO closing to complete a business combination or redeem public shares and liquidate. It qualifies as an emerging growth company and a smaller reporting company, allowing reduced reporting and compliance requirements.